E2 |
estrogen |
E3 |
estriol |
PPARα |
peroxisome proliferator-activated receptor α |
PPARβ
|
peroxisome proliferator-activated receptor β
|
PGC1α |
peroxisome proliferator-activated receptor gamma coactivator 1 α |
PCG1β
|
peroxisome proliferator-activated receptor gamma coactivator 1 β
|
ERR1 |
estrogen-related receptor 1 |
BMI |
body mass index |
SWAN |
Study of Women’s Health Across the Nation |
SAT |
subcutaneous adipose tissue |
TG |
triacylglycerol |
TC |
total cholesterol |
FFA |
free fatty acid |
AT-LPL |
adipose tissue lipoprotein lipase |
FFM |
fat-free mass |
LBM |
lean body mass |
DEXA |
dual-energy X-ray absorptiometry |
BMR |
basal metabolic rate |
REE |
resting energy expenditure |
VLDLs |
very-low-density lipoproteins |
LDLs |
low-density lipoproteins |
HDLs |
high-density lipoproteins |
LCAT |
lecithin-cholesterol acyltransferase |
CETP |
cholesterol ester transfer protein |
CHD |
coronary heart disease |
FSH |
follicle-stimulating hormone |
WHILA |
Women’s Health in the Lund Area |
OVX |
ovariectomized |
CEBPb |
CCAAT-enhancer-binding proteins |
ER α |
estrogen receptor α |
ER β
|
estrogen receptor β
|
Adipo ER α |
adipocyte-specific ER α |
AHA |
American Heart Association |
ACC |
American College of Cardiology |
RDA |
Recommended dietary allowance |
CVD |
cardiovascular disease |
DHA |
docosahexaenoic acid |
EPA |
eicosapentaenoic acid |
PUFA |
polyunsaturated fatty acid |
CHD |
coronary heart disease |
HRT |
hormone replaces therapy |
TBX2 |
thromboxane B2 |